NFS Journal (Nov 2024)

A review of clinical and preclinical data supporting a role for resveratrol in the treatment of common respiratory tract pathogens

  • Giulio Dinardo,
  • Michele Miraglia del Giudice,
  • Lorenzo Drago,
  • Maria Daglia,
  • Alessandra Gori,
  • Attilio Varricchio,
  • Chiara Trincianti,
  • Enrico Tondina,
  • Francesco Paolo Brunese,
  • Giulia Brindisi,
  • Matteo Naso,
  • Anna Maria Zicari,
  • Giorgio Ciprandi,
  • Cristiana Indolfi

Journal volume & issue
Vol. 37
p. 100194

Abstract

Read online

Respiratory infections are a relevant issue during infancy and childhood, constituting a major source of morbidity and imposing a substantial burden on healthcare systems. Conditions such as bronchiolitis, pneumonia, and influenza exemplify the gravity of these infections among pediatric populations. In the context of this health challenge, resveratrol, a naturally occurring polyphenolic antioxidant has emerged as a focal point of extensive research, known for its antioxidant, anti-inflammatory, and antimicrobial properties. This comprehensive review delves into the compound's extensive antimicrobial activities against a diverse range of bacteria and viruses, both as a standalone agent and in combination with conventional antibiotics. This compound exhibits notable antiviral activity against viruses implicated in severe respiratory infections, offering a potential therapeutic avenue. By exploring the antiviral mechanisms and highlighting the anti-inflammatory potential of resveratrol, this comprehensive overview contributes to a deeper understanding of its applicability in mitigating the complexities associated with pediatric respiratory infections.

Keywords